Abstract

Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews etal. (2019).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
J Scott Andrews ... Noam Y Kirson
Alzheimer's & Dementia: Translational Research & Clinical Interventions | VOL. 5
J Scott Andrews, et. al.J Scott Andrews ... Noam Y Kirson
01 Jan 2019
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
Paul S Aisen ... Clifford R Jack
Alzheimer's & Dementia: The Journal of the Alzheimer's Association | VOL. 15
Paul S Aisen, et. al.Paul S Aisen ... Clifford R Jack
13 Oct 2018
The Application of Minimal Clinically Important Differences in Palliative Research: Interpretation of Results of a Systematic Review.
Julie M Waldfogel ... Sydney M Dy
Journal of pain and symptom management | VOL. 64
Julie M Waldfogel, et. al.Julie M Waldfogel ... Sydney M Dy
01 Dec 2022
Memory loss in Alzheimer's disease: are the alterations in the UPR network involved in the cognitive impairment?
Gabriela Martínez ... Claudia Duran-Aniotz
Frontiers in Aging Neuroscience | VOL. 6
Gabriela Martínez, et. al.Gabriela Martínez ... Claudia Duran-Aniotz
01 Jan 2014
View more papers

More From: Alzheimer's & dementia (New York, N. Y.)

Paper Title
Journal
Date
Author
Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective.
Haakon B Nygaard ... Julie M Robillard
Alzheimer's & dementia (New York, N. Y.) | VOL. 10
Haakon B Nygaard, et. al.Haakon B Nygaard ... Julie M Robillard
01 Apr 2024
Correction to "Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production".
-
Alzheimer's & dementia (New York, N. Y.) | VOL. 10
--
01 Apr 2024
Genetic associations with psychosis and affective disturbance in Alzheimer's disease.
Inga Margret Antonsdottir ...
Alzheimer's & dementia (New York, N. Y.) | VOL. 10
Inga Margret Antonsdottir, et. al.Inga Margret Antonsdottir ...
01 Apr 2024
Induction of tauopathy in a mouse model of amyloidosis using intravenous administration of adeno-associated virus vectors expressing human P301L tau.
Dylan J Finneran ... David Morgan
Alzheimer's & dementia (New York, N. Y.) | VOL. 10
Dylan J Finneran, et. al.Dylan J Finneran ... David Morgan
01 Apr 2024
View more papers